Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Neonatal Glutathione in Preterm Birth
NCT03596125Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Nov 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in preterm birth, sponsored by CHU de Nantes. Started Nov 2018; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03596125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596125.